TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102 ...

Completed enrollment of Cohort C in the Phase 1 ALLOHA™ trial; patients to be treated with commercial-ready manufacturing process Received FDA clearance of INDs for TSC-102-A01 and TSC-102-A03 ...

PJX Resource's Sheeted Veins with Gold up to 28 g/t in a Possible Reduced Intrusion Related Gold System (RIRGS) in the Sullivan Mining District

TORONTO, ON / ACCESS Newswire / February 26, 2026 / The Gar target on PJX Resources Inc.'s ("PJX") Zinger Property has visible gold associated with sheeted and structurally controlled quartz veins in ...